Exact Sciences shares hit new all-time highs in after-hours trading Monday after the Madison cancer test company released third-quarter results well above analysts’ expectations.
FluGen Inc. has been awarded $14.4 million through the DOD’s Congressionally Directed Medical Research Programs Peer Reviewed Medical Research Program’s (PRMRP) mechanism to conduct clinical challenge-studies against mismatched influenza strains with its lead universal flu vaccine, RedeeFlu™.
Invenra, a Madison startup on a cancer-fighting mission, is boosting its treasury by $3.1 million.The money, from more than two dozen investors, according to documents filed with federal regulators, is part of a $6 million round the company plans to raise, co-founder and CEO Roland Green said. READ MORE
JangoBio, a biotech company developing a therapy to reduce the negative effects of aging, could be starting human trials as early as next year.
The University of Wisconsin–Madison community lost a significant figure with the passing of Dr. Mark Cook. Dr. Cook, whose research yielded advances in human health and food production, held 40 patents and founded three startups, including Ab E Discovery.
A University Research Park based biotech startup with ambitious goals is adding staff and expanding testing capabilities as it seeks early-stage investment. JangoBio is trying to develop regenerative therapy products which would diminish the effects of aging caused by imbalanced hormones. By regrowing certain tissues in the body, the company seeks to recreate the hormonal […]
Dr. Lynn Allen-Hoffmann, Founder and former CEO of Stratatech Corporation, now a Mallinckrodt company; current Senior Vice President of Regenerative Medicine at Mallinckrodt; and Professor of Pathology and Laboratory Medicine at University of Wisconsin-Madison, will receive the Hector F. DeLuca Scientific Achievement Award, celebrating her exceptional success in developing regenerative medicine products that have the […]
The “Drones & Cones” event at URP highlighted how drone technology can enhance entrepreneurial efforts.
Stemina Biomarker Discovery Inc. announced that Dr. Heiner Dreismann, former head of Roche Molecular Diagnostics, has joined the Board of Directors to bring his extensive experience in commercialization strategy to the company as it prepares to go to market with its autism diagnostic test panel.
DotCom Therapy, a Madison, WI-based startup that has developed software allowing the dozens of therapists it employs to provide remote speech therapy services to schoolchildren, captured first place in one of Wisconsin’s more closely watched pitch competitions on Monday.